{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:17:28Z","timestamp":1787775448793,"version":"build-2784847793"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amphotericin B (AMB) has been the irreplaceable drug of choice for countless fungal and protozoal infections. One of the lesser-known adverse effects of AMB is Pancytopenia - very rare with very few cases reported - most commonly observed following prolonged administration. We report the case of a patient suffering from visceral leishmaniasis, who developed worsening pancytopenia four to five days after being administered a single bolus dose of Liposomal Amphotericin B (L-AMB). The diagnosis was clinical and management involved supportive care, and granulocyte-macrophage colony-stimulating factor (GM-CSF). AMB is an effective drug, but is also associated with numerous side effects. Physicians are well-versed with the more frequently seen adverse drug reactions and their management. However, pancytopenia, being a rare adverse reaction to AMB, is less known and can be easily overlooked. This case report aims to ensure that the physicians must be aware of such possibilities in the first place to make swift diagnoses and management. The condition itself is seemingly self-limiting, although GM-CSF may be needed in refractory cases. It\u2019s true that few previous case reports have indicated pancytopenia in association with prolonged AMB exposure, but we believe certain conditions may predispose a patient to a more acute presentation - as seen in our case.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_321_22","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T07:34:07Z","timestamp":1666164847000},"page":"5692-5695","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Amphotericin B induced pancytopenia"],"prefix":"10.4103","volume":"11","author":[{"given":"Esha","family":"Vaish","sequence":"first","affiliation":[{"name":"Medical Student, Department of Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh K.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Medical Student, Department of Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnawaz A.","family":"Ansari","sequence":"additional","affiliation":[{"name":"Medical Student, Department of Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Medical Student, Department of Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"B2-20240828","first-page":"177","article-title":"A review of complications of amphotericin-B therapy:Recommendations for prevention and management","volume":"14","author":"Maddux","year":"1980","journal-title":"Drug Intell Clin Pharm"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/AAC.14.2.270","article-title":"Erythropoietin concentration in amphotericin B-induced anemia","volume":"14","author":"MacGregor","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1537-2995.1981.21181127488.x","article-title":"Altered platelet function and circulation induced by amphotericin B in leukemic patients after platelet transfusion","volume":"21","author":"Kulpa","year":"1981","journal-title":"Transfusion (Paris)"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"332","DOI":"10.7326\/0003-4819-96-3-332","article-title":"Amphotericin-B-induced thrombocytopenia","volume":"96","author":"Chan","year":"1982","journal-title":"Ann Intern Med"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijantimicag.2011.07.004","article-title":"Safety analysis of liposomal amphotericin B in adult patients:Anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia","volume":"38","author":"Shigemi","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B:30 years of clinical experience","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3109\/10428194.2015.1010080","article-title":"Hematological toxicities associated with amphotericin B formulations","volume":"56","author":"Falci","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00104-019-0994-1","article-title":"[Visceral leishmaniasis","volume":"90","author":"Wilhelm","year":"2019","journal-title":"Chir Z Alle Geb Oper Medizen"},{"key":"B10-20240828","first-page":"879","article-title":"Clinical and hematological features of visceral leishmaniasis at Mymensingh medical college hospital","volume":"29","author":"Malek","year":"2020","journal-title":"Mymensingh Med J MMJ"},{"key":"B11-20240828","first-page":"1745","author":"Jameson","journal-title":"Harrison's Principles of Internal Medicine"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_321_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:17:31Z","timestamp":1787771851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_321_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_321_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"2022-02-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}